First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness, Resistance Mechanisms, and Prognosis of Different Subsequent Treatments. - Nie, Naifu; Li, Jianghua; Zhang, Jian; Dai, Jie; Liu, Zhulin; Ding, Zhenyu; Wang, Yubo; Zhu, Mengxiao; Hu, Chen; Han, Rui; Tang, Huan; Li, Li; et al. (Clinical Medicine Insights: Oncology, 2022)